National Inflammatory Bowel Disease Awareness Week

Floor Speech

Date: Nov. 20, 2014
Location: Washington, DC

Mr. MORAN. Mr. Speaker, I rise today on behalf of the Crohn's and Colitis patient community in observance of National Inflammatory Bowel Disease (IBD) Awareness Week. As the Co-Chair of the Crohn's and Colitis Caucus, I have enjoyed working with my colleague Ander Crenshaw to raise awareness of and improve access to treatments for IBD.
Our caucus has worked to champion funding for IBD research at the National Institutes of Health (NIH). This has led to accomplishments like the identification of the first gene linked to Crohn's Disease (NOD/CARD15), which will lead to better treatments and a cure for IBD, and the discovery of Remicade, the only biologic drug for treatment of both Crohn's disease and ulcerative colitis.
We have also been strong advocates for the IBD Epidemiology program at the Centers for Disease Control and Prevention (CDC). This program yields invaluable information about the prevalence of IBD in the US and expands our knowledge about the demographic characteristics of this vulnerable population. The data derived from this study will not only provide an analysis of the etiology of the disease, but could also explain why the course of illness varies among individuals and what environmental or treatment factors improve patient outcomes.
While there is currently no known cure for IBD, we can already see the importance of Congress's continued support of IBD research. National IBD Awareness Week offers the opportunity to build upon our efforts for the Crohn's and Colitis patient community.
I have been honored by the opportunity to lead the Crohn's and Colitis Caucus, and I urge my colleagues to speak out in support of IBD research efforts and to raise awareness for IBD.